Clinical Trial Update: Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: First People's Hospital of Foshan | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN